Etiology in the Elderly Nutritional deficiencies (iron, B12, folate) Anaemia of chronic disease/inflammation Chronic kidney disease Myelodysplastic syndromes Occult malignancies (esp. GI tract) Drug-related (NSAIDs, chemotherapy)
Pathophysiology Reduced erythropoietin response Decreased marrow reserve Chronic inflammation (↑ hepcidin, ↓ iron availability) Nutrient malabsorption (gastritis, PPI use)
Clinical Features Fatigue, weakness, dizziness Dyspnea, angina, palpitations Cognitive decline, frailty, falls Masked by comorbidities
Diagnostic Workup CBC + indices (MCV, MCH, RDW) Reticulocyte count Iron studies (Ferritin, Transferrin saturation) B12 & Folate levels Renal function (eGFR, creatinine) Bone marrow biopsy if unexplained GI evaluation for occult bleeding
Management Principles Treat underlying cause Iron therapy (oral/IV depending on tolerance) B12 & folate supplementation Erythropoiesis-stimulating agents (ESAs) in CKD Blood transfusion (severe/symptomatic cases) Manage comorbidities & frailty
Special Considerations Polypharmacy & drug interactions Frailty & functional status Risk–benefit: transfusion vs. ESA therapy Monitor treatment side effects
Case Discussion 75-year-old with fatigue & melena Hb 8.5 g/dL, microcytic, low ferritin Colonoscopy → bleeding colonic carcinoma Management → iron correction + oncological referral
Summary Anaemia common in elderly; multifactorial Always investigate underlying cause Tailor management to comorbidities & frailty Improves quality of life and reduces morbidity
References WHO Guidelines UpToDate Clinical Review Harrison’s Principles of Internal Medicine Recent peer-reviewed articles